Analgesics in Japan

Date: October 25, 2017
Pages: 21
Price:
US$ 990.00
Publisher: Euromonitor International Ltd
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: A8742053AE0EN
Leaflet:

Download PDF Leaflet

Analgesics in Japan recorded healthy current value growth in 2017. Systemic analgesics containing ibuprofen as a main active ingredient performed well, as did combination products containing ibuprofen or loxoprofen. Positive performances were also recorded by topical analgesics/anaesthetic products with the active ingredients felbinac, indomethacin and diclofenac sodium. These product types benefited from the launch of a new tax deduction scheme to promote self-medication.

Euromonitor International's Analgesics in Japan report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2012-2016, allowing you to identify the sectors driving growth. Forecasts to 2021 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Analgesics market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Headlines
Prospects
Robust Growth Expected for Analgesics
Domestic Players Establish Specialised OTC Companies
Loxoprofen Sodium Hydrate Products Approved for Switching
Competitive Landscape
Ssp the Leading Player in Systemic Analgesics
Hisamitsu the Leading Player in Topical Analgesics/anaesthetic
Daiichi Sankyo Looking To Double the Sales of Its Loxonin S Brand
Category Data
  Table 1 Sales of Analgesics by Category: Value 2012-2017
  Table 2 Sales of Analgesics by Category: % Value Growth 2012-2017
  Table 3 Sales of Topical Analgesics/Anaesthetic by Format: % Value 2012-2017
  Table 4 NBO Company Shares of Analgesics: % Value 2013-2017
  Table 5 LBN Brand Shares of Analgesics: % Value 2014-2017
  Table 6 Forecast Sales of Analgesics by Category: Value 2017-2022
  Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2017-2022
Executive Summary
Consumer Health Benefits From New Tax System Designed To Promote Self-medication
New Consumer Health Products Target Specific Demographic Groups
Competitive Environment in Consumer Health Remains Fragmented
Market Value Share of Drugstores/parapharmacies Channel Increases
Consumer Health Set To Benefit From Self-medication and Diversification
Market Indicators
  Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2012-2017
  Table 9 Life Expectancy at Birth 2012-2017
Market Data
  Table 10 Sales of Consumer Health by Category: Value 2012-2017
  Table 11 Sales of Consumer Health by Category: % Value Growth 2012-2017
  Table 12 NBO Company Shares of Consumer Health: % Value 2013-2017
  Table 13 LBN Brand Shares of Consumer Health: % Value 2014-2017
  Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2012-2017
  Table 15 Distribution of Consumer Health by Format: % Value 2012-2017
  Table 16 Distribution of Consumer Health by Format and Category: % Value 2017
  Table 17 Forecast Sales of Consumer Health by Category: Value 2017-2022
  Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2017-2022
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
  Summary 1 OTC: Switches 2015-2017
Definitions
Sources
  Summary 2 Research Sources
Skip to top


OTC Pharmaceuticals in Japan US$ 350.00 Sep, 2016 · 35 pages
Adult Mouth Care in Japan US$ 990.00 Nov, 2016 · 25 pages
Calming and Sleeping in Japan US$ 990.00 Mar, 2015 · 24 pages

Ask Your Question

Analgesics in Japan
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: